1Fonseca R,Barlogie B,Bataille R,et al.Genetics and cytogenetics of multiple myeloma:a workshop report.Cancer Res,2004,64:1546-1558.
2Fonseca R,Debes-Marun CS,Picken EB,et al.The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.Blood,2003,102:2562-2567.
3Smadja NV,Leroux D,Soulier J,et al.Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.Genes Chromosomes Cancer,2003,38:234-239.
4Ho PJ.Chromosomal and genetic abnormalities in myeloma.Clin Lab Haematol,2002,24:259-269.
5Yata K,Sadahira Y,Otsuki T,et al.Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1.Br J Haematol,2001,114:591-599.
6Fonseca R,Blood EA,Oken MM,et al.Myeloma and the t(11;14)(q13 ;q32); evidence for a biologically defined unique subset of patients.Blood,2002,99:3735-3741.
7Avet-Loiseau H,Garand R,Lode L,et al.Translocation t(11;14)(q13;q32) is the hallmark of IgM,IgE,and nonsecretory multiple myeloma variants.Blood,2003,101:1570-1571.
8Robillard N,Avet-Loiseau H,Garand R,et al.CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.Blood,2003,102:1070-1071.
9Fabris S,Agnelli L,Mattioli M,et al.Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.Genes Chromosomes Cancer,2005,42:117-127.
10Intini D,Baldini L,Fabris S,et al.Analysis of FGFR3 gene mutations in multiple myeloma patients with t (4;14).Br J Haematol,2001,114:362-364.
